Endocannabinoid modulation of dopaminergic motor circuits

Endocannabinoid modulation of dopaminergic motor circuits

There is substantial evidence supporting a role for the endocannabinoid system as a modulator of the dopaminergic activity in the basal ganglia, a forebrain system that integrates cortical information to coordinate motor activity regulating signals. In fact, the administration of plant-derived, synt...

Full description

Bibliographic Details
Main Authors:	Teresa eMorera-Herreras, Cristina eMiguelez, Asier eAristieta, José Ángel eRuiz-Ortega, Luisa eUgedo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2012-06-01
Series:	Frontiers in Pharmacology
Subjects:	Basal Ganglia Dopamine Electrophysiology Endocannabinoids Motor circuits
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00110/full

Similar Items

Interaction between the 5-HT system and the basal ganglia: Functional implication and therapeutic perspective in Parkinson’s disease
by: Cristina eMiguelez, et al.
Published: (2014-03-01)

Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation
by: Sergio Vegas-Suárez, et al.
Published: (2022-08-01)

Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
by: Berhanu Geresu Kibret, et al.
Published: (2023-03-01)

Many roads to motor deficits: loss of dopamine signaling in direct or indirect basal ganglia pathway leads to akinesia through distinct physiological mechanisms
by: Gwendolyn G Calhoon, et al.
Published: (2010-12-01)

Acute and chronic effects by nicotine on striatal neurotransmission and synaptic plasticity in the female rat brain
by: Erika Lucente, et al.
Published: (2023-01-01)

Contribution of Endocannabinoids to Intrinsic Motivation for Undirected Singing in Adult Zebra Finches
by: Yunbok Kim, et al.
Published: (2022-04-01)

CALBINDIN CONTENT AND DIFFERENTIAL VULNERABILITY OF MIDBRAIN EFFERENT DOPAMINERGIC NEURONS IN MACAQUES
by: Iria G Dopeso-Reyes, et al.
Published: (2014-12-01)

Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson’s disease
by: Maria Mancini, et al.
Published: (2024-05-01)

Endocannabinoid dynamics gate spike-timing dependent depression and potentiation
by: Yihui Cui, et al.
Published: (2016-02-01)

The role of dopamine and endocannabinoid systems in prefrontal cortex development: Adolescence as a critical period
by: Kate Zara Peters, et al.
Published: (2022-11-01)

Midbrain dopaminergic neurons generate calcium and sodium currents and release dopamine in the striatum of pups
by: Diana Carolina Ferrari, et al.
Published: (2012-03-01)

Slowly evolving dopaminergic activity modulates the moment-to-moment probability of reward-related self-timed movements
by: Allison E Hamilos, et al.
Published: (2021-12-01)

TEMPORAL CHANGES IN THE ENDOCANNABINOID SYSTEM ALONG THE BASAL GANGLIA AFTER VIRAL VECTOR-MEDIATED OVEREXPRESSION OF ALPHA-SYNUCLEIN IN THE MOUSE SUBSTANTIA NIGRA
by: Maider Zubelzu, et al.
Published: (2023-10-01)

The endocannabinoid system: an overview
by: Natalia eBattista, et al.
Published: (2012-03-01)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
by: Cristina Miguelez, et al.
Published: (2017-09-01)

The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats
by: Yolanda López-Tofiño, et al.
Published: (2024-09-01)

Neuromodulation of Aerobic Exercise—A Review
by: Saskia eHeijnen, et al.
Published: (2016-01-01)

The endocannabinoid system and spermatogenesis
by: Paola eGrimaldi, et al.
Published: (2013-12-01)

Automated procedure to detect subtle motor alterations in the balance beam test in a mouse model of early Parkinson’s disease
by: Raphaëlle Bidgood, et al.
Published: (2024-01-01)

Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons
by: Daniel J Galtieri, et al.
Published: (2017-10-01)

Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions
by: R.C. Evans
Published: (2022-10-01)

Commentary: Comment on the Effect of Endocannabinoid System on Rat Behavior
by: Ali Roohbakhsh
Published: (2017-01-01)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)

Differential effects of toluene and ethanol on dopaminergic neurons of the ventral tegmental area
by: Sudarat Nimitvilai, et al.
Published: (2016-09-01)

Pan-phylum In Silico Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery
by: Bethany A. Crooks, et al.
Published: (2022-07-01)

Dopamine-glutamate interactions in the basal ganglia /
by: Jones, Susan
Published: (2012)

Dopamine depletion weakens direct pathway modulation of SNr neurons
by: Asier Aristieta, et al.
Published: (2024-06-01)

La marihuana y el sistema endocannabinoide: de una droga de recreo a una nueva alternativa farmacológica
by: Marcela De Jesús Sánchez, et al.
Published: (2018-08-01)

Effect of MCH1, a fatty-acid amide hydrolase inhibitor, on the depressive-like behavior and gene expression of endocannabinoid and dopaminergic-signaling system in the mouse nucleus accumbens
by: C. Medina-Saldivar, et al.
Published: (2024-02-01)

Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
by: Stephen Schultz, et al.
Published: (2021-03-01)

Non-opioid Analgesics and the Endocannabinoid System
by: Ruhan Deniz Topuz, et al.
Published: (2020-11-01)

Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease
by: Abdelhamid eBenazzouz, et al.
Published: (2014-05-01)

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications
by: Harshavardhan Lingegowda, et al.
Published: (2022-10-01)

Endocannabinoid Systetm: Neuropharmacological Implications
by: Vivek Kumar Sharma, et al.
Published: (2016-06-01)

Microglial Endocannabinoid Signalling in AD
by: Lucia Scipioni, et al.
Published: (2022-04-01)

Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
by: Zhao H, et al.
Published: (2024-06-01)

BIONOTE as an Innovative Biosensor for Measuring Endocannabinoid Levels
by: Simone Grasso, et al.
Published: (2021-01-01)

The endocannabinoid system and stroke: A focused review
by: Bradley Kolb, et al.
Published: (2019-01-01)

Endocannabinoid System: Chemical Characteristics and Biological Activity
by: Bismarck Rezende, et al.
Published: (2023-01-01)

Membrane environment and endocannabinoid signaling
by: Mauro eMaccarrone
Published: (2010-10-01)